Skip to main content

Table 1 Clinical material and efficacy of the 45 patients

From: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

Characters NO. CR, n (%) PR, n (%) SD, n(%) PD, n (%)
Gender      
   Male 19 0 15.8(3) 36.8(7) 47.4(9)
   Female 26 0 46.1(12) 38.5(10) 15.4(4)
Age(year)      
   < 70 35 0 34.3(12) 37.1(13) 28.6(10)
   ≥70 10 0 30.0(3) 40.0(4) 30.0(3)
Smoking status      
   Smokers 17 0 17.6(3) 41.2(7) 41.2(7)
   Non-smokers 28 0 42.9(12) 35.7(10) 21.4(6)
Tumor histology      
   Adeno. 26 0 38.5(10) 42.3(11) 19.2(5)
   BAC 4 0 75.0(3) 25.0(1) 0.0(0)
Squamous 10 0 10.0(1) 30.0(3) 60.0(6)
   Adenosquamous 5 0 20.0(1) 40.0(2) 40.0(2)
Stage      
   IIIb 14 0 28.6(4) 50.0(7) 21.4(3)
   IV 31 0 35.4(11) 32.3(10) 32.3(10)
Brain metastasis 4 0 75.0(3) 25.0(1) 0.0(0)
PS value      
   ≤ 2 32 0 37.5(12) 37.5(12) 25.0(8)
   3~4 13 0 23.0(3) 38.5(5) 38.5(5)